(November 12, 2018, 12:14 PM EST) -- CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on Nov. 8 denied a motion by insurer Gemini Insurance Co. to intervene in settlement allocation for its insured, Endo Pharmaceuticals Inc., and a subsidiary (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div., 2018 U.S. Dist. LEXIS 191521)....